Table 1.
Schizophrenia | Bipolar disorder | Post‐traumatic stress disorder | |
---|---|---|---|
Differences at the level of sex | |||
Incidence | M > F |
M > F Type I M < F Type II |
M < F |
Age of onset | M < F | M < F # | Unknown |
Symptom severity | M > F | F = M, depending on BD type | M < F |
Symptom presentation | M > F for comorbid issues |
M > F for mania M < F for depression |
M < F for dissociation and threat sense |
Treatment response | M < F for response to treatment, remission, recovery | Unknown | M < F for response to treatment |
Interactions and effects of gonadal steroid hormones | |||
Blood oestradiol levels | ↓ in M and F | Mixed/inconclusive | Unknown |
Blood progesterone levels | ↓ in M and F | Mixed/inconclusive | ↓ in F |
Menstrual cycle effects | ↑ symptoms during low‐hormone phases | ↑ symptoms during low‐hormone phases | ↑ symptoms during low‐hormone phases# |
Effects of menopause | ↑ symptoms, prevalence | ↑ depression and ↓ mania | Unknown |
Effects of exogenous oestradiol | Oestradiol and raloxifene improved symptoms in M and F | Oestradiol improved manic and psychotic symptoms | Oestradiol improved performance in analogue trauma tasks in non‐PTSD subjects |
M: Male; F: Female; <: less or worse; >: greater or better; ↑: increased; ↓: decreased; #: preliminary or weaker evidence.